AGL Stock Recent News

LOS ANGELES, CA / ACCESSWIRE / May 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against agilon health, inc. ("agilon" or "the Company") (NYSE:AGL) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Although the revenue and EPS for Agilon (AGL) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the first quarter 2024 after the market closes on Tuesday, May 7, 2024, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (929) 526-1599 for international partic.

T, AGL and ALTO have been added to the Zacks Rank #5 (Strong Sell) List on March 25, 2023.

agilon health, Inc. (AGL) Q4 2023 Earnings Call Transcript

The headline numbers for Agilon (AGL) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Agilon Health (AGL) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.14 per share a year ago.

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the fourth quarter and full year 2023 after the market closes on Tuesday, February 27, 2023, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (929) 526-1599 for.

The provider of support services for primary care physicians anticipates medical margins for fiscal 2023 of between $340 million and $360 million, down from an earlier forecast of $455 million to $470 million.

Shares of Agilon Health Inc. AGL, -0.25% were indicated down more than 1% in Friday's premarket, after the health care services company lowered its 2023 margin outlook, citing higher costs, but provided an upbeat 2024 outlook. “Higher-than-expected costs became visible to us in mid-December during the November close process given updated data from health plans and will impact our FY2023 medical margins,” said Chief Executive Steve Sell.